These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37770623)

  • 1. Angiogenesis in the eye.
    Lewis S
    Nat Rev Neurosci; 2023 Nov; 24(11):654. PubMed ID: 37770623
    [No Abstract]   [Full Text] [Related]  

  • 2. Tat PTD-endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops.
    Zhang X; Li Y; Cheng Y; Tan H; Li Z; Qu Y; Mu G; Wang F
    Biochim Biophys Acta; 2015 Jun; 1850(6):1140-9. PubMed ID: 25662072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DZ2002 alleviates corneal angiogenesis and inflammation in rodent models of dry eye disease via regulating STAT3-PI3K-Akt-NF-κB pathway.
    Wu CM; Mao JW; Zhu JZ; Xie CC; Yao JY; Yang XQ; Xiang M; He YF; Tong X; Litifu D; Xiong XY; Cheng MN; Zhu FH; He SJ; Lin ZM; Zuo JP
    Acta Pharmacol Sin; 2024 Jan; 45(1):166-179. PubMed ID: 37605050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis: possible analogies between the eye and the inner ear.
    Campos EC; Gattegna R; Raimondi MC; Pirodda A
    Med Hypotheses; 2012 May; 78(5):644-5. PubMed ID: 22348992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the ocular angiogenesis animal models.
    Montezuma SR; Vavvas D; Miller JW
    Semin Ophthalmol; 2009; 24(2):52-61. PubMed ID: 19373687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and inhibition of angiogenesis in the eye].
    Cursiefen C; Schönherr U
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):341-51. PubMed ID: 9333658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 6. Ocular models of angiogenesis.
    Aguilar E; Dorrell MI; Friedlander D; Jacobson RA; Johnson A; Marchetti V; Moreno SK; Ritter MR; Friedlander M
    Methods Enzymol; 2008; 444():115-58. PubMed ID: 19007663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis capacity as a diagnostic marker for human eye tumors.
    Tapper D; Langer R; Bellows AR; Folkman J
    Surgery; 1979 Jul; 86(1):36-40. PubMed ID: 572101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors controlling ocular angiogenesis.
    Casey R; Li WW
    Am J Ophthalmol; 1997 Oct; 124(4):521-9. PubMed ID: 9323943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.
    Rahimi N
    Exp Eye Res; 2006 Nov; 83(5):1005-16. PubMed ID: 16713597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes.
    Oshima Y; Shukunami C; Honda J; Nishida K; Tashiro F; Miyazaki J; Hiraki Y; Tano Y
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1814-23. PubMed ID: 12714610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.
    Sene A; Chin-Yee D; Apte RS
    Trends Mol Med; 2015 Jan; 21(1):43-51. PubMed ID: 25457617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis factors in ocular tissues of normal rabbits on chorioallantoic membrane assay.
    Okamoto T; Oikawa S; Toyota T; Goto Y
    Tohoku J Exp Med; 1988 Jan; 154(1):63-70. PubMed ID: 2452497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.
    Spranger J; Osterhoff M; Reimann M; Möhlig M; Ristow M; Francis MK; Cristofalo V; Hammes HP; Smith G; Boulton M; Pfeiffer AF
    Diabetes; 2001 Dec; 50(12):2641-5. PubMed ID: 11723044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1-Based Antiangiogenic Therapy.
    Sims JN; Lawler J
    J Ocul Pharmacol Ther; 2015 Sep; 31(7):366-70. PubMed ID: 26352160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.
    Michael IP; Westenskow PD; Hacibekiroglu S; Greenwald AC; Ballios BG; Kurihara T; Li Z; Warren CM; Zhang P; Aguilar E; Donaldson L; Marchetti V; Baba T; Hussein SM; Sung HK; Iruela-Arispe ML; Rini JM; van der Kooy D; Friedlander M; Nagy A
    EMBO Mol Med; 2014 May; 6(5):604-23. PubMed ID: 24705878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
    Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
    Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of ocular angiogenesis and its molecular mediators.
    Siemerink MJ; Augustin AJ; Schlingemann RO
    Dev Ophthalmol; 2010; 46():4-20. PubMed ID: 20703029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis inhibitors: current & future directions.
    Mousa SA; Mousa AS
    Curr Pharm Des; 2004; 10(1):1-9. PubMed ID: 14754401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies.
    Liu P; Sun D; Zhang S; Chen S; Wang X; Li H; Wei F
    Cell Biosci; 2024 Feb; 14(1):21. PubMed ID: 38341583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.